Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 075141
Company: GALT PHARMS

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ORPHENGESIC ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 385MG;30MG;25MG TABLET;ORAL Discontinued None No No
ORPHENGESIC FORTE ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770MG;60MG;50MG TABLET;ORAL Prescription AB No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/29/1998 ORIG-1 Approval Review (PDF)

Label is not available on this site.

 https://www.accessdata.fda.gov/drugsatfda_docs/anda/98/75141ap.pdf

ORPHENGESIC

There are no Therapeutic Equivalents.

ORPHENGESIC FORTE

TABLET;ORAL; 770MG;60MG;50MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770MG;60MG;50MG TABLET;ORAL Prescription No AB 074654 SANDOZ
ORPHENGESIC FORTE ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 770MG;60MG;50MG TABLET;ORAL Prescription No AB 075141 GALT PHARMS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English